Transdermal scopolamine patches have been extensively prescribed for nonspecific dizziness and vestibular disorders. Patient response may be favorable and side effects are generally limited to xerostomia and blurred vision. However, subtle dependency and outright addiction may develop. Tapered reduction and drug elimination will suffice to eliminate the dependency. However, hospitalization may be necessary to treat severe cases of physiological chemical dependency. Long-term use of transdermal scopolamine patches carries a risk of chemical dependency. Prescribing physicians should review and heed the manufacturer's recommended use.
ClissoldS.P., HeelR.C.Transdermal hyoscine (scopolamine): A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs1985; 29: 189–207.
3.
WoodC.D., GraybielA., McDonoughR.Human centrifuge studies on the relative effectiveness of some antimotion sickness drugs. Aerospace Med1966 (February); 187–9.
American Hospital Formulary Service.American Society of Hospital Pharmacists, Bethesda, MD, 1994; 754–7.
6.
GilmanA.G.The Pharmacological Basis of Therapeutics.Pergamon Press, New York, 1990; 150–65.
7.
BabinR.W., BalkanyT.J., FeeW.E.Transdermal scopolamine in the treatment of acute vertigo. Ann Otol Rhinol Laryngol1984; 93: 25–7.
8.
HiginsG.A., KilpatrickG.J., BunceK.T.5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-in-duced emesis in the ferret. Br J Pharmacol1989; 97: 247–55.
9.
AndrewsP.L.R., DavisC.J., BinghamS.The abdominal visceral innervation and the emetic reflex: Pathways, pharmacology and plasticity. Can J Physiol Pharmacol1990; 68: 325–45.
